Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Study sponsor: Glaukos Corporation
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2028-06Estimated
Enrollment · participants510Estimated
Source updated2026-03-30Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.